Phenytoin Sodium and Magnesium Sulphate in the Management of Eclampsia

Although magnesium sulfate is the most widely employed drug for the prevention and management of convulsions in eclampsia, studies have suggested that phenytoin may be more specific. To assess this issue, the author studied 22 patients with eclampsia who had received only a single dose of 1–2 mg of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Obstetric anesthesia digest 1990-10, Vol.10 (3), p.131-131
1. Verfasser: Dommisse, J
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 131
container_issue 3
container_start_page 131
container_title Obstetric anesthesia digest
container_volume 10
creator Dommisse, J
description Although magnesium sulfate is the most widely employed drug for the prevention and management of convulsions in eclampsia, studies have suggested that phenytoin may be more specific. To assess this issue, the author studied 22 patients with eclampsia who had received only a single dose of 1–2 mg of clonazepam following a first convulsion. In the hospital, patients were randomly assigned to receive a loading dose of 4 g of MgSO4 followed by an infusion of 1–2 g/h, or a loading dose of 500 mg of phenytoin, followed by two 500 mg doses given over 4 hours at an interval of 12 hours. Periodic serum levels of Mg and phenytoin were determined 30 minutes after the loading dose and then every 6 hours. Blood pressures in excess of 115 mmHg diastolic were controlled with dihydralazine infusion. Side effects for each drug were recorded and pregnancy was terminated as soon as convulsions and hypertension were controlled.
doi_str_mv 10.1097/00132582-199010000-00012
format Article
fullrecord <record><control><sourceid>wolterskluwer_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00132582_199010000_00012</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>00132582-199010000-00012</sourcerecordid><originalsourceid>FETCH-LOGICAL-c942-edbac2f509f937f20d6af61bd718769f6fd9ef6bd5d02934e351f0ff2c852b8f3</originalsourceid><addsrcrecordid>eNp1kM1OwzAQhC0EEqXwDn6BwNqunfiIqhaQikBqD9wsJ95tAvmp4lQVb09KgRsjrUaj3dnDxxgXcCvApncAQkmdyURYCwJGJeMIecYmQiuTaGX1OZuATHVijH67ZFcxvgNIEDabsOVrie3n0FUtX3eh2jfct4E_-22L8ZjW-3pX-gH5eDCUOG5av8UG24F3xBdF7ZtdrPw1uyBfR7z58SnbLBeb-WOyenl4mt-vksLOZIIh94UkDZasSklCMJ6MyEMqstRYMhQsksmDDiCtmqHSgoBIFpmWeUZqyrLT26LvYuyR3K6vGt9_OgHuiMP94nB_ONw3jrE6O1UPXT1gHz_q_QF7V6Kvh9L9R1F9Ad8wYwU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Phenytoin Sodium and Magnesium Sulphate in the Management of Eclampsia</title><source>Journals@Ovid Complete</source><creator>Dommisse, J</creator><creatorcontrib>Dommisse, J</creatorcontrib><description>Although magnesium sulfate is the most widely employed drug for the prevention and management of convulsions in eclampsia, studies have suggested that phenytoin may be more specific. To assess this issue, the author studied 22 patients with eclampsia who had received only a single dose of 1–2 mg of clonazepam following a first convulsion. In the hospital, patients were randomly assigned to receive a loading dose of 4 g of MgSO4 followed by an infusion of 1–2 g/h, or a loading dose of 500 mg of phenytoin, followed by two 500 mg doses given over 4 hours at an interval of 12 hours. Periodic serum levels of Mg and phenytoin were determined 30 minutes after the loading dose and then every 6 hours. Blood pressures in excess of 115 mmHg diastolic were controlled with dihydralazine infusion. Side effects for each drug were recorded and pregnancy was terminated as soon as convulsions and hypertension were controlled.</description><identifier>ISSN: 0275-665X</identifier><identifier>EISSN: 1536-5395</identifier><identifier>DOI: 10.1097/00132582-199010000-00012</identifier><language>eng</language><publisher>Williams &amp; Wilkins</publisher><ispartof>Obstetric anesthesia digest, 1990-10, Vol.10 (3), p.131-131</ispartof><rights>Williams &amp; Wilkins 1990. All Rights Reserved.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Dommisse, J</creatorcontrib><title>Phenytoin Sodium and Magnesium Sulphate in the Management of Eclampsia</title><title>Obstetric anesthesia digest</title><description>Although magnesium sulfate is the most widely employed drug for the prevention and management of convulsions in eclampsia, studies have suggested that phenytoin may be more specific. To assess this issue, the author studied 22 patients with eclampsia who had received only a single dose of 1–2 mg of clonazepam following a first convulsion. In the hospital, patients were randomly assigned to receive a loading dose of 4 g of MgSO4 followed by an infusion of 1–2 g/h, or a loading dose of 500 mg of phenytoin, followed by two 500 mg doses given over 4 hours at an interval of 12 hours. Periodic serum levels of Mg and phenytoin were determined 30 minutes after the loading dose and then every 6 hours. Blood pressures in excess of 115 mmHg diastolic were controlled with dihydralazine infusion. Side effects for each drug were recorded and pregnancy was terminated as soon as convulsions and hypertension were controlled.</description><issn>0275-665X</issn><issn>1536-5395</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1990</creationdate><recordtype>article</recordtype><recordid>eNp1kM1OwzAQhC0EEqXwDn6BwNqunfiIqhaQikBqD9wsJ95tAvmp4lQVb09KgRsjrUaj3dnDxxgXcCvApncAQkmdyURYCwJGJeMIecYmQiuTaGX1OZuATHVijH67ZFcxvgNIEDabsOVrie3n0FUtX3eh2jfct4E_-22L8ZjW-3pX-gH5eDCUOG5av8UG24F3xBdF7ZtdrPw1uyBfR7z58SnbLBeb-WOyenl4mt-vksLOZIIh94UkDZasSklCMJ6MyEMqstRYMhQsksmDDiCtmqHSgoBIFpmWeUZqyrLT26LvYuyR3K6vGt9_OgHuiMP94nB_ONw3jrE6O1UPXT1gHz_q_QF7V6Kvh9L9R1F9Ad8wYwU</recordid><startdate>199010</startdate><enddate>199010</enddate><creator>Dommisse, J</creator><general>Williams &amp; Wilkins</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>199010</creationdate><title>Phenytoin Sodium and Magnesium Sulphate in the Management of Eclampsia</title><author>Dommisse, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c942-edbac2f509f937f20d6af61bd718769f6fd9ef6bd5d02934e351f0ff2c852b8f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1990</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Dommisse, J</creatorcontrib><collection>CrossRef</collection><jtitle>Obstetric anesthesia digest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dommisse, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phenytoin Sodium and Magnesium Sulphate in the Management of Eclampsia</atitle><jtitle>Obstetric anesthesia digest</jtitle><date>1990-10</date><risdate>1990</risdate><volume>10</volume><issue>3</issue><spage>131</spage><epage>131</epage><pages>131-131</pages><issn>0275-665X</issn><eissn>1536-5395</eissn><abstract>Although magnesium sulfate is the most widely employed drug for the prevention and management of convulsions in eclampsia, studies have suggested that phenytoin may be more specific. To assess this issue, the author studied 22 patients with eclampsia who had received only a single dose of 1–2 mg of clonazepam following a first convulsion. In the hospital, patients were randomly assigned to receive a loading dose of 4 g of MgSO4 followed by an infusion of 1–2 g/h, or a loading dose of 500 mg of phenytoin, followed by two 500 mg doses given over 4 hours at an interval of 12 hours. Periodic serum levels of Mg and phenytoin were determined 30 minutes after the loading dose and then every 6 hours. Blood pressures in excess of 115 mmHg diastolic were controlled with dihydralazine infusion. Side effects for each drug were recorded and pregnancy was terminated as soon as convulsions and hypertension were controlled.</abstract><pub>Williams &amp; Wilkins</pub><doi>10.1097/00132582-199010000-00012</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0275-665X
ispartof Obstetric anesthesia digest, 1990-10, Vol.10 (3), p.131-131
issn 0275-665X
1536-5395
language eng
recordid cdi_crossref_primary_10_1097_00132582_199010000_00012
source Journals@Ovid Complete
title Phenytoin Sodium and Magnesium Sulphate in the Management of Eclampsia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T21%3A39%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wolterskluwer_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phenytoin%20Sodium%20and%20Magnesium%20Sulphate%20in%20the%20Management%20of%20Eclampsia&rft.jtitle=Obstetric%20anesthesia%20digest&rft.au=Dommisse,%20J&rft.date=1990-10&rft.volume=10&rft.issue=3&rft.spage=131&rft.epage=131&rft.pages=131-131&rft.issn=0275-665X&rft.eissn=1536-5395&rft_id=info:doi/10.1097/00132582-199010000-00012&rft_dat=%3Cwolterskluwer_cross%3E00132582-199010000-00012%3C/wolterskluwer_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true